After successfully raising more than $637,000 to participate a last-ditch, potentially life-saving clinical trial, Matthew Schreindorfer is now at New York's Sloan Kettering Memorial Cancer Center receiving an experimental T-cell treatment.
from CBC | Health News http://ift.tt/1B2YO11
Aucun commentaire:
Enregistrer un commentaire